Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).
- Conditions
- Hand, Foot, and Mouth Disease (HFMD)Herpangina
- Interventions
- Biological: Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell)Biological: Medium-dose tetravalent inactivated enterovirus vaccine (Vero cell)Biological: High-dose tetravalent inactivated enterovirus vaccine (Vero cell) )Biological: EV71 inactivated enterovirus vaccine (Vero cell) )(for ages 6-71 months）Biological: placebo (for ages 6-12 years)
- First Posted Date
- 2024-12-31
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 552
- Registration Number
- NCT06754384
- Locations
- 🇨🇳
Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Hangzhou, China
Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
- Conditions
- Hand, Foot, and Mouth Disease（HFMD)
- Interventions
- Biological: bivalent enterovirus vaccine (Vero cell), inactivatedBiological: Enterovirus Type 71 Vaccine (Vero Cell), Inactivated
- First Posted Date
- 2024-12-16
- Last Posted Date
- 2025-01-01
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 8000
- Registration Number
- NCT06734832
- Locations
- 🇨🇳
Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China
🇨🇳Fujian Provincial Center for Disease Control and Prevention, Fujian, China
🇨🇳Guangdong Provincial Center for Disease Control and Prevention, Guangdong, China
Booster Dose of sIPV Co-administered With MMR and HepA-I.
- Conditions
- Poliomyelitis
- Interventions
- Biological: MMRBiological: HepA-IBiological: sIPV
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 960
- Registration Number
- NCT06442449
- Locations
- 🇨🇳
Jiangsu Center for Disease Control and Prevention (Jiangsu Institute of Public Health), Nanjing, Jiangsu, China
Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers
- First Posted Date
- 2024-04-04
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 200
- Registration Number
- NCT06346834
- Locations
- 🇨🇳
Disease Control and Prevention Center, Xiaonan District, Xiaogan City, Xiaogan, China
Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in Indonesia
- Conditions
- Hand, Foot and Mouth Disease
- Interventions
- Diagnostic Test: PCR
- First Posted Date
- 2024-02-09
- Last Posted Date
- 2024-02-09
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT06251219
The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students
- Conditions
- MumpsInfluenza
- Interventions
- Biological: Mumps vaccine, Live (MV)Biological: Influenza Vaccine, inactivated, quadrivlent(QIV)
- First Posted Date
- 2024-01-17
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 400
- Registration Number
- NCT06208683
- Locations
- 🇨🇳
Qindu Distric Center for Disease Prevention and Control, Xianyang, Shaanxi, China
🇨🇳Xingping Center for Disease Prevention and Control, Xianyang, Shaanxi, China
🇨🇳Yuyang Distict Center for Disease Prevention and Control, Yulin, Shaanxi, China
Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial
- Conditions
- Hand, Foot and Mouth DiseaseHerpangina
- Interventions
- Biological: medium dose Bivalent Enterovirus Vaccine (Vero Cell), InactivatedBiological: high dose Bivalent Enterovirus Vaccine (Vero Cell), InactivatedBiological: low dose Bivalent Enterovirus Vaccine (Vero Cell), InactivatedBiological: Enterovirus type EV71 vaccine (Vero cell), Inactivated
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 744
- Registration Number
- NCT06063057
- Locations
- 🇨🇳
Dayao County Center for Disease Control and Prevention, Chuxiong, Yunnan, China
Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old
- Conditions
- Hepatitis A
- Interventions
- Biological: Healive (hepatitis A vacine(human diploid cell), inactivated)
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2024-08-21
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 1092
- Registration Number
- NCT06058416
- Locations
- 🇨🇳
Liaoning Center for Disease Control and Prevention, Shenyang, Liaoning, China
Immunogenicity of After Primary Immunization and Booster Immunization of sIPV
- Conditions
- Polio
- Interventions
- Other: no intervention
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2023-10-26
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 233
- Registration Number
- NCT06058429
- Locations
- 🇨🇳
Jiangxi Center for Disease Control and Prevention, Nanchang, Jiangxi, China
A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
- Conditions
- Seasonal Influenza
- Interventions
- Biological: Quadrivalent influenza vaccine(0.5ml)Biological: Trivalent influenza vaccine(BV)Biological: Trivalent influenza vaccine(BY)Biological: Quadrivalent influenza vaccine(0.25ml)
- First Posted Date
- 2023-09-22
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Sinovac Biotech Co., Ltd
- Target Recruit Count
- 3300
- Registration Number
- NCT06049927
- Locations
- 🇨🇳
Huoqiu County Center for Disease Control and Prevention, Lu'an, Anhui, China
🇨🇳Zhushan County Center for Diseases Control and Prevention, Shiyan, Hubei, China
🇨🇳Nanzhang County Center for Disease Prevention and Control, Xiangyang, Hubei, China